Medicines Archive | Page 2 Of 4 | Polypharma: Generics Developer

Medicines produced by 3D printer

May 26, 2020 | Medicines

Research using 3D printers is entering its next phase. Research is being carried out into how tablets can be produced in the future using 3D printing. Here the starting substances for the medicines are mixed and melted in a pharmaceutical melt extruder and processed...

Reduction of concomitant diseases in stable coronary heart disease and diabetes mellitus

May 19, 2020 | Medicines

In a COMPASS study (Cardiovascular Outcomes for People Using Anticoagulation Strategies), taking 100mg of aspirin and 2.5mg of rivaroxaban twice daily demonstrated that the risk of myocardial infarction or stroke was significantly reduced. Cardiovascular mortality and...

Dapagliflozin tablets for type 2 diabetes

May 15, 2020 | Medicines

Dapagliflozin is the first molecule in the class of SGLT2 inhibitors to be marketed in France alone or in combination with metformin. Studies show that this oral antidiabetic reduces the morbidity and mortality of type 2 diabetics and helps prevent hospitalisation for...

Solriamfetol film-coated tablets for narcolepsy and sleep apnea

May 13, 2020 | Medicines

A new drug for the treatment of narcolepsy and obstructive sleep apnea is coming to market in Germany in the form of Solriamfetol 75mg and 150mg film-coated tablets. Solriamfetol is a psychoanaleptic that inhibits the reuptake of dopamine and noradrenaline....

Dapagliflozin 5mg and 10mg film-coated tablet helps with heart failure

May 4, 2020 | Medicines

The SGLT-2 inhibitor (sodium-glucose cotransporter 2) dapagliflozin counteracts progression of heart failure and death of cardiovascular cause in heart failure patients with impaired left ventricular function, regardless of diabetes status. SGLT-2 inhibitors are...

New paracetamol- and caffeine-based analgesic

May 4, 2020 | Medicines

Paracetamol (500mg) and caffeine (50mg) tablets are used for the symptomatic treatment of pain of mild to moderate intensity and/or febrile conditions. These may be permitted for adults and children weighing 50kg or more (15 years and older) and may be issued without...

« Older Entries

Next Entries »